These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 18326476
1. [Therapy of non-nosocomial pneumonia]. Drömann D, Schaaf B. MMW Fortschr Med; 2008 Jan 24; 150(3-4):31-4; quiz 35. PubMed ID: 18326476 [No Abstract] [Full Text] [Related]
2. [Comparative analysis of guidelines for the treatment of community-acquired pneumonias]. Rodríguez de Castro F. Arch Bronconeumol; 1999 Jun 24; 35(6):253-6. PubMed ID: 10410203 [No Abstract] [Full Text] [Related]
3. Prescription of macrolides in community-acquired pneumonia: science or art? Rello J. Chest; 1998 May 24; 113(5):1155-8. PubMed ID: 9596285 [No Abstract] [Full Text] [Related]
4. Impact of positive microbiological diagnosis on management and prognosis of severe community-acquired pneumonia. Leroy O, d'Escrivan T, Georges H, Alfandari S. Chest; 2003 Sep 24; 124(3):1179-80. PubMed ID: 12970059 [No Abstract] [Full Text] [Related]
5. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Mandell LA, Bartlett JG, Dowell SF, File TM, Musher DM, Whitney C, Infectious Diseases Society of America. Clin Infect Dis; 2003 Dec 01; 37(11):1405-33. PubMed ID: 14614663 [No Abstract] [Full Text] [Related]
7. [Antibiotic treatment for legionellosis]. Calbo E, Garau J. Enferm Infecc Microbiol Clin; 2006 Dec 01; 24(6):357-9. PubMed ID: 16792935 [No Abstract] [Full Text] [Related]
8. The clinical efficacy of fluoroquinolone and macrolide combination therapy compared with single-agent therapy against community-acquired pneumonia caused by Legionella pneumophila. Nakamura S, Yanagihara K, Izumikawa K, Seki M, Kakeya H, Yamamoto Y, Senjyu H, Saito A, Kohno S. J Infect; 2009 Sep 01; 59(3):222-4. PubMed ID: 19592113 [No Abstract] [Full Text] [Related]
9. Coverage of atypical pathogens for hospitalised patients with community-acquired pneumonia is not guided by clinical parameters. Piso RJ, Arnold C, Bassetti S. Swiss Med Wkly; 2013 Sep 01; 143():w13870. PubMed ID: 24089030 [Abstract] [Full Text] [Related]
16. Prospective, randomised study to compare empirical treatment versus targeted treatment on the basis of the urine antigen results in hospitalised patients with community-acquired pneumonia. Falguera M, Ruiz-González A, Schoenenberger JA, Touzón C, Gázquez I, Galindo C, Porcel JM. Thorax; 2010 Feb 01; 65(2):101-6. PubMed ID: 19703825 [Abstract] [Full Text] [Related]